Cargando…

2-deoxy-D-glucose as India’s Response to COVID-19: A Commitment or Conceit?

2-deoxy-d-glucose (2-DG) has recently been approved for the treatment of moderate to severe COVID-19 patients in India. Here we discuss whether this is a well-thought-out step towards the long-term management of COVID-19 or a decision taken at the spur of the moment. 2-DG, an anticancer drug, also h...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Ritwik, Roy, Dipayan, Chatterjee, Subhankar, Benito-León, Julián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Greater Baltimore Medical Center 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195081/
https://www.ncbi.nlm.nih.gov/pubmed/35711390
http://dx.doi.org/10.55729/2000-9666.1052